Recruiting

Virtual Reality

Sponsor:

Wake Forest University Health Sciences

Code:

NCT07324577

Conditions

Radiation Therapy

Virtual Reality

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

standard of care

Virtual Reality Intervention

Radiation Therapist Survey

Study Details

Brief summary:

The purpose of this study is to evaluate the use and functionality of virtual reality (VR) during radiation therapy treatments for patients with prostate, breast, lung, or head and neck cancer.

Conditions

Radiation Therapy

Virtual Reality

Study ID

NCT07324577

Start date

May 7, 2026

Status verified date

Jul, 2026

Completion date

Feb 1, 2029

Anticipated

Primary completion date

Feb 1, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Patients:

Inclusion Criteria:

  • Participants planned for radiation therapy for 15 or more treatments with non-neutron generating energies (10 MV or less) per study PI for prostate, breast, lung, or head and neck cancer. Neutrons have the potential to damage the VR headset device and are generated for energies above 10 MV.
  • Age 18 years or older at the time of consent.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-33 or Karnofsky (KPS) 30-100 at the time of enrollment.
  • Ability to understand and the willingness to sign an IRB-approved informed consent document directly.

Exclusion Criteria:

  • Previous radiation therapy
  • VR device is determined to impede the radiation dosage during the VR device simulation and treatment planning
  • Participants with primary brain tumors, brain metastases, and cancer involving the sinuses, orbits, nose, or ears, are excluded from this clinical trial because the VR device may obstruct the area being treated
  • Participants with uncontrolled inter-current illness including but not limited to psychiatric illness/social situations that would limit compliance with study requirements per treating radiation oncologist.
  • Participants with known epilepsy, significant motion sickness, severe uncorrected visual impairment, severe uncorrected hearing impairment, or seizures, per participant report.
  • Participants with skin defects, infections, or open wounds in the area where the VR device is applied (face or scalp) or in the eyes per treating radiation oncologist.
  • Participants with pacemakers, internal defibrillators, hearing aid, or other implanted medical device. The Meta Quest device contains magnets and components that emit magnetic/electromagnetic fields which could affect the operation of nearby electronics and medical devices.

Radiation Therapists:

Inclusion Criteria:

  • Agreement to participate after reviewing the information sheet
  • Radiation therapist at AHWFBCCC High Point who has treated at least one participant who enrolled on to the study and used the VR device.

Study Design

Enrollment

54 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

other: Standard of care

Standard of care radiation therapy for prostate, lung, breast cancer without using the VR headset

other: Virtual Reality intervention

Participants will wear the VR headset (Quest 2 by Meta) during radiation therapy

other: Radiation Therapists

Providers that administer the VR intervention

Interventions

standard of care

Radiation therapy for prostate cancer, breast cancer, lung cancer, or head and neck cancer.

Virtual Reality Intervention

Participants will wear the VR headset (Meta Quest 2) during standard of care radiation therapy

Radiation Therapist Survey

Radiation therapists will be asked about their experiences and proficiency with using the VR device.

Primary outcome measure

  • VR Use During Treatment [ Time Frame: Periprocedural (each treatment visit) ]
  • VR Functionality [ Time Frame: Periprocedural (each treatment visit) ]

Central Contacts and Locations

Central contacts

Sheri Whittington

336-878-6107Sheri.Whittington@Advocatehealth.org

Locations

Atrium Health Wake Forest Baptist Hayworth Cancer Center

Recruiting

High Point, North Carolina, United States, 27262

Contacts

Sheri Whittington

336-878-6107Sheri.Whittington@Advocatehealth.org

Principal Investigator:

Stephanie Parker, MS

More Information

Sponsor

Wake Forest University Health Sciences

Last update posted

Jul 7, 2026

Last verified

Jul, 2026

Keywords

  • Virtual Reality
  • Cancer
  • Radiation Therapy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Wake Forest University Health Sciences on 2026-07-07.